Zealand Pharma A/S Cash Flow Conversion Efficiency

Latest as of December 2025: -0.070x

Zealand Pharma A/S cash flow conversion efficiency. Based on the latest financial reports, Zealand Pharma A/S (ZEAL) has a cash flow conversion efficiency ratio of -0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-1.04 Billion ≈ $-163.16 Million USD) by net assets (Dkr14.83 Billion ≈ $2.32 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zealand Pharma A/S (2007–2025)

Cash flow conversion efficiency of Zealand Pharma A/S from 2007 to 2025. This chart illustrates how Zealand Pharma A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zealand Pharma A/S (ZEAL) share price today for real-time trading data and today's change.

Zealand Pharma A/S Cash Flow Conversion Ratio Explained

Zealand Pharma A/S cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zealand Pharma A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zealand Pharma A/S ranked by their cash flow conversion efficiency. Also see Zealand Pharma A/S stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Pattern Group Inc. Series A Common Stock NASDAQ:PTRN	0.023x
KEYMED BIOSCIENCES -0001 F:64Z	N/A
Beacon Financial Corporation NYSE:BBT	-0.005x
Shanxi Taigang Stainless Steel Co Ltd SHE:000825	0.019x
Indosat Tbk JK:ISAT	0.164x
CN LGY.PWR.GR.UNSP.ADR/10 F:6WX0	N/A
Koninklijke BAM Groep NV AS:BAMNB	-0.153x
Privia Health Group Inc NASDAQ:PRVA	0.000x

Annual Cash Flow Conversion Efficiency for Zealand Pharma A/S (2007–2025)

The table below shows the annual cash flow conversion efficiency of Zealand Pharma A/S from 2007 to 2025. Review Zealand Pharma A/S free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr14.83 Billion ≈ $2.32 Billion	Dkr6.53 Billion ≈ $1.02 Billion	0.440x	+507.72%
2024-12-31	Dkr8.62 Billion ≈ $1.35 Billion	Dkr-930.82 Million ≈ $-145.63 Million	-0.108x	+59.58%
2023-12-31	Dkr1.59 Billion ≈ $249.21 Million	Dkr-425.67 Million ≈ $-66.60 Million	-0.267x	+76.86%
2022-12-31	Dkr815.91 Million ≈ $127.66 Million	Dkr-942.21 Million ≈ $-147.42 Million	-1.155x	+11.60%
2021-12-31	Dkr927.80 Million ≈ $145.16 Million	Dkr-1.21 Billion ≈ $-189.62 Million	-1.306x	-123.26%
2020-12-31	Dkr1.18 Billion ≈ $184.16 Million	Dkr-688.72 Million ≈ $-107.75 Million	-0.585x	-77.57%
2019-12-31	Dkr1.24 Billion ≈ $194.43 Million	Dkr-409.45 Million ≈ $-64.06 Million	-0.329x	+20.11%
2018-12-31	Dkr1.12 Billion ≈ $174.65 Million	Dkr-460.40 Million ≈ $-72.03 Million	-0.412x	+21.81%
2017-12-31	Dkr528.47 Million ≈ $82.68 Million	Dkr-278.75 Million ≈ $-43.61 Million	-0.527x	-458.73%
2016-12-31	Dkr278.19 Million ≈ $43.53 Million	Dkr40.90 Million ≈ $6.40 Million	0.147x	+116.45%
2015-12-31	Dkr252.23 Million ≈ $39.46 Million	Dkr-225.41 Million ≈ $-35.27 Million	-0.894x	-435.63%
2014-12-31	Dkr252.83 Million ≈ $39.56 Million	Dkr-42.18 Million ≈ $-6.60 Million	-0.167x	+68.90%
2013-12-31	Dkr316.14 Million ≈ $49.46 Million	Dkr-169.62 Million ≈ $-26.54 Million	-0.537x	-484.38%
2012-12-31	Dkr491.01 Million ≈ $76.82 Million	Dkr68.54 Million ≈ $10.72 Million	0.140x	+3511.47%
2011-12-31	Dkr441.40 Million ≈ $69.06 Million	Dkr-1.81 Million ≈ $-282.56K	-0.004x	+97.02%
2010-12-31	Dkr407.11 Million ≈ $63.70 Million	Dkr-55.98 Million ≈ $-8.76 Million	-0.138x	+70.26%
2009-12-31	Dkr132.92 Million ≈ $20.80 Million	Dkr-61.45 Million ≈ $-9.61 Million	-0.462x	-237.00%
2008-12-31	Dkr208.63 Million ≈ $32.64 Million	Dkr-28.62 Million ≈ $-4.48 Million	-0.137x	+42.25%
2007-12-31	Dkr242.37 Million ≈ $37.92 Million	Dkr-57.57 Million ≈ $-9.01 Million	-0.238x	--

About Zealand Pharma A/S

CO:ZEAL Denmark Biotechnology

Market Cap

$2.58 Billion

Dkr16.49 Billion DKK

Market Cap Rank

#5158 Global

#34 in Denmark

Share Price

Dkr234.10

Change (1 day)

+0.91%

52-Week Range

Dkr221.80 - Dkr545.80

All Time High

Dkr954.00